ATE74758T1 - MIXTURES OF POLAR AND NEUTRAL LIPIDS FOR PROTECTION OF THE GASTROINTESTINAL TRACT. - Google Patents

MIXTURES OF POLAR AND NEUTRAL LIPIDS FOR PROTECTION OF THE GASTROINTESTINAL TRACT.

Info

Publication number
ATE74758T1
ATE74758T1 AT88301336T AT88301336T ATE74758T1 AT E74758 T1 ATE74758 T1 AT E74758T1 AT 88301336 T AT88301336 T AT 88301336T AT 88301336 T AT88301336 T AT 88301336T AT E74758 T1 ATE74758 T1 AT E74758T1
Authority
AT
Austria
Prior art keywords
mixtures
gastrointestinal tract
neutral lipids
compositions
polar
Prior art date
Application number
AT88301336T
Other languages
German (de)
Inventor
Lenard M Lichtenberger
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE74758T1 publication Critical patent/ATE74758T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Disclosed are compositions composed of unique mixtures of phospholipids and neutral lipids and methods of employing such compositions to treat the luminal lining of the gastrointestinal tract in the prevention or treatment of ulcerogenic processes such as peptic ulcer disease and inflammatory bowel disease. Compositions including mixtures of saturated or unsaturated phospholipids, together with saturated or unsaturated triglycerides and/or sterols, are shown to provide a surprising ulcer protective efficacy in experimental models. Further enhancement of activity is found upon the addition of a polyvalent cation or antioxidant to the various lipid mixtures.
AT88301336T 1987-02-17 1988-02-17 MIXTURES OF POLAR AND NEUTRAL LIPIDS FOR PROTECTION OF THE GASTROINTESTINAL TRACT. ATE74758T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/015,394 US4918063A (en) 1987-02-17 1987-02-17 Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
EP88301336A EP0287198B1 (en) 1987-02-17 1988-02-17 Mixtures of polar and neutral lipids for protecting the gastronointestinal tract

Publications (1)

Publication Number Publication Date
ATE74758T1 true ATE74758T1 (en) 1992-05-15

Family

ID=21771153

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88301336T ATE74758T1 (en) 1987-02-17 1988-02-17 MIXTURES OF POLAR AND NEUTRAL LIPIDS FOR PROTECTION OF THE GASTROINTESTINAL TRACT.

Country Status (8)

Country Link
US (1) US4918063A (en)
EP (1) EP0287198B1 (en)
JP (1) JP2820688B2 (en)
AT (1) ATE74758T1 (en)
CA (1) CA1310909C (en)
DE (1) DE3870016D1 (en)
ES (1) ES2038285T3 (en)
GR (1) GR3004396T3 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
US5811119A (en) * 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
WO1993013751A1 (en) * 1992-01-16 1993-07-22 Board Of Regents, The University Of Texas System Formulation and use of carotenoids in treatment of cancer
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn
US5478819A (en) * 1993-06-23 1995-12-26 Simo Tarpila Phospholipid composition and use thereof
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
ATE265207T1 (en) 1997-02-21 2004-05-15 Abbott Lab USE OF POLYUNSATURATED FATTY ACIDS TO PREVENT NECROTIC ENTEROCOLITIS
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
US7141266B2 (en) * 1998-05-21 2006-11-28 Beech-Nut Nutrition Corporation Baby-food compositions enhancing visual acuity and methods therefor
US6579551B1 (en) 1998-05-21 2003-06-17 Beech-Nut Nutrition Corporation Baby-food compositions containing egg yolk and methods therefor
US6149964A (en) * 1998-05-21 2000-11-21 Beech-Nut Nutrition Corporation Egg yolk-containing baby food compositions and methods therefor
US7413759B2 (en) * 1998-05-21 2008-08-19 Beech-Nut Nutrition Corporation Method of enhancing cognitive ability in infant fed DHA containing baby-food compositions
DE69927466T3 (en) 1998-12-22 2010-02-11 Unilever N.V. Cosmetic use of petroselinic acid
BR0110316A (en) 2000-04-07 2005-01-18 Regents For The University Of Unique Zwitterionic Phospholipid and Bisphosphonate Compositions and Use of the Compositions as Bisphosphate Delivery Systems with Reduced Gly Toxicity
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
US20100173876A1 (en) * 2000-12-19 2010-07-08 The Board Of Regents Of The University Of Texas System Oil-based nsaid compositions and methods for making and using same
US20080051373A1 (en) * 2003-07-31 2008-02-28 The Board Of Regents Of The University Of Texas System Parenteral preparations of GI-safer phospholipid-associated anti-inflammatories and methods of preparation and use
WO2005027933A1 (en) * 2003-09-23 2005-03-31 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Unsaturated phosphatidylcholines and uses thereof
DE602004027655D1 (en) * 2003-11-03 2010-07-22 Yissum Res Dev Co METHOD FOR SELECTING CATIONIC OR ANIONIC LIPOSOMES FOR THE TREATMENT OF A TREATMENT MASK AND THIS SET
MX2009000658A (en) * 2006-07-19 2009-01-30 Univ Texas Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease.
EP2172203A1 (en) * 2008-09-17 2010-04-07 Giuliani S.P.A. Pharmaceutical composition for the treatment of gastrointestinal irritation disorders
US8471047B1 (en) * 2010-12-09 2013-06-25 Surfatech Corporation Mixed glyceryl esters
EP2760433B1 (en) 2011-09-29 2023-05-31 PLx Opco Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
EP2848251B1 (en) * 2013-09-12 2017-04-19 King Saud University Extracts and isolated compounds from Cakile arabica for treatment of ulcer
CA3172595A1 (en) 2020-03-26 2021-09-30 Ronald Zimmerman Pharmaceutical carriers capable of ph dependent reconstitution and methods for making and using same
CN112516129B (en) * 2021-01-09 2022-04-29 兰州大学 Application of trans-1, 3-dilinolein in preparation of drugs for treating gastric cancer, drugs for invigorating stomach, health products and foods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2556592C2 (en) * 1975-12-16 1986-10-09 A. Nattermann & Cie GmbH, 5000 Köln Medicinal preparations based on oily solutions of phospholipids
DE2856333C2 (en) * 1978-12-27 1983-09-22 A. Nattermann & Cie GmbH, 5000 Köln Oral medicines with anti-inflammatory effects
DE3028074C2 (en) * 1980-07-22 1983-12-08 Kurt Kampffmeyer Mühlenvereinigung KG, 2000 Hamburg Process for the manufacture of a product containing lecithin
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same
DE3374914D1 (en) * 1982-04-12 1988-01-28 Univ Texas Methods and compositions for treating gastro-intestinal ulcer diesease
DE3369644D1 (en) * 1982-11-22 1987-03-12 Teijin Ltd Artificial lung surfactant and remedy for respiratory distress syndrome containing it as active principle
DE3346525C2 (en) * 1983-12-22 1987-03-19 A. Nattermann & Cie GmbH, 5000 Köln Pharmaceutical preparation with special 1,2-diacyl-glycero-3-phosphocholines for the treatment of gastrointestinal diseases
AU594066B2 (en) * 1985-07-26 1990-03-01 Yeda Research And Development Co. Ltd. A special lipid mixture for membrane fluidization

Also Published As

Publication number Publication date
GR3004396T3 (en) 1993-03-31
DE3870016D1 (en) 1992-05-21
JP2820688B2 (en) 1998-11-05
US4918063A (en) 1990-04-17
EP0287198A3 (en) 1988-11-17
JPS63301824A (en) 1988-12-08
EP0287198B1 (en) 1992-04-15
ES2038285T3 (en) 1993-07-16
EP0287198A2 (en) 1988-10-19
CA1310909C (en) 1992-12-01

Similar Documents

Publication Publication Date Title
ATE74758T1 (en) MIXTURES OF POLAR AND NEUTRAL LIPIDS FOR PROTECTION OF THE GASTROINTESTINAL TRACT.
CA2003692A1 (en) Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract and additional applications for surfactant replacement therapy and other conditions requiring rapid phospholipid _absorption to surfaces
BR8007609A (en) SURGICAL EXTRACTOR TO EXPIRE STRANGE BODIES THROUGH THE NATURAL WAYS OF THE HUMAN BODY
ATE106867T1 (en) 13-TRANS-RETIN ACID ESTER.
DE69415535D1 (en) METHOD FOR REGULATING SEXUAL REACTION IN HUMANS
ATE226437T1 (en) (PHOSPHO)LIPIDS TO FIGHT HEPATITIS B INFECTION
GB2070429B (en) Use of perfluorocarbon as burn treatment
IT7849523A0 (en) 3-1H-TETRAZOL-5-IL-4H-PYRIDO 1,2-A PYRIMIDIN-4-ONI SUBSTITUTES USEFUL IN PARTICULAR AS THERAPEUTIC AGENTS TO INHIBIT ALLERGIC REACTIONS AND PROCEDURE FOR THE PRODUCTION OF THE SAID DERIVATIVES
BR8803709A (en) UMECTANT FOR A SKIN TREATMENT COMPOSITION AND ITS COMPOSITION
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
NO160579C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OMEGA (1,4,5-TRIFENYLIMIDAZOL-2-YLOXY) ALKANIC ACIDS AND THEIR DERIVATIVES.
FI971494A7 (en) Enterlipid liposomes and their therapeutic use
MX7070E (en) PROCEDURE TO PREPARE USEFUL SOY ISOLATES IN THE FORMATION OF IMITATION CHEESES
ATE109001T1 (en) AGENTS FOR STIMULATING TEAR SECRETION.
DE69319338D1 (en) SIMPLY UNSATURATED FATS AS NUTRITIONAL ADDITIVES TO MINIMIZE THE CONSEQUENCES OF CATABOLIC DISEASES
NO870397D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ORGANIC PLATINA COMPLEXS.
IT1206973B (en) CONTINUOUS PROCEDURE AND APPARATUS FOR THE WHITENING OF TRIGLYCERIDES CI OILS WITH ADSORBENTS
Granke et al. Longitudinal study of cerebral spinal fluid drainage in polyethylene glycol—conjugated superoxide dismutase in paraplegia associated with thoracic aortic cross-clamping
NO802030L (en) PROCEDURE FOR THE MANUFACTURING OF MAGIC ACID NUTRITIZING AGENTS, MAGIC ACID NUTRITIZING AGENTS AND A PROCEDURE FOR TREATING HYPERSURITY AND DISEASES RELATED TO THIS
GR82545B (en) Pharmaceutical preparation for treating rheumatics
JPS51116092A (en) Footwear for automatically treating defecation of seriously limbs handicapped patient or the like
MX6274E (en) PROCEDURE FOR THE PREPARATION OF PARMACEUTICAL COMPOSITIONS CONTAINING DETOXIFIED CYTOSTATIC ALCOHILANTS
ES535091A0 (en) PROCEDURE FOR OBTAINING A HYDROCARBON FRACTION FROM BEESWAX.
NL7604937A (en) PROCEDURE FOR COVERING LARGE COMPONENTS AS WELL AS SOUNKED CONSTRUCTION OBTAINED BY APPLICATION OF THE PROCEDURE.
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee